Beckman coulter announces fda clearance of dxc 500i clinical analyzer, an integrated clinical chemistry and immunoassay system

The new dxc 500i analyzer offers flexibility and scalability with broad chemistry and immunoassay assay menu brea, calif. , march 10, 2025 /prnewswire/ -- beckman coulter diagnostics, a clinical diagnostics leader, today announced that the new dxc 500i clinical analyzer, an integrated clinical chemistry and immunoassay analyzer, received 510(k) clearance from the u.s. food and drug administration.
DHR Ratings Summary
DHR Quant Ranking